Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
amgen
biotech
4
×
boston blog main
boston top stories
inclisiran
4
×
life sciences
national blog main
national top stories
new york blog main
4
×
new york top stories
regeneron pharmaceuticals
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
pcsk9
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
alirocumab
cholesterol
clinical trials
evolocumab
fda
glaxosmithkline
medco
medicines co.
novartis
What
cholesterol
drug
new
roundup
wave
abbvie’s
according
acquire
agreed
akcea
barbecuing
billion
bio
biotech
brings
camping
cardiologist
cases
cash
center
centers
check
cigarettes
company
compound
conference
control
day
deal
deaths
disease
drugs
electronic
expensive
faces
fda
financial
flop
foe
healthcare
Language
unset
4
×
Current search:
inclisiran
×
biotech
×
" new york blog main "
×
unset
×
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
4 years ago
Biotech Roundup: Vaping Toll Rises, NASH News, Akcea Shakeup & More
@xconomy.com
4 years ago
Bio Roundup: Cholesterol Check, J&J’s Opioid Hit, AbbVie’s Flop & More
@xconomy.com
4 years ago
New PCSK9 Cholesterol Drug Faces Tough Foe. (Hint: Not Cholesterol.)